Publication | Closed Access
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin)
20
Citations
47
References
2010
Year
Theoretical Dose-escalation StudyBiological Effective DoseRadiation TherapyMedicineRadionuclide TherapyRadiopharmaceutical TherapyPharmacotherapyImmunotherapyPharmacologyRadiation Oncology90Y-ibritumomab TiuxetanDosimetry
| Year | Citations | |
|---|---|---|
Page 1
Page 1